Primecap Management’s Kyntra Bio, Inc. Common Stock KYNB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $721K | Sell |
|
|||||
|
2025
Q2 | $475K | Sell |
|
|||||
|
2025
Q1 | $1.16M | Sell |
|
|||||
|
2024
Q4 | $2.44M | Sell |
|
|||||
|
2024
Q3 | $3.96M | Sell |
|
|||||
|
2024
Q2 | $12.2M | Sell |
|
|||||
|
2024
Q1 | $33.9M | Sell |
|
|||||
|
2023
Q4 | $12.8M | Sell |
|
|||||
|
2023
Q3 | $12.7M | Buy |
|
|||||
|
2023
Q2 | $36.9M | Sell |
|
|||||
|
2023
Q1 | $264M | Buy |
|
|||||
|
2022
Q4 | $223M | Buy |
|
|||||
|
2022
Q3 | $171M | Sell |
|
|||||
|
2022
Q2 | $139M | Sell |
|
|||||
|
2022
Q1 | $160M | Buy |
|
|||||
|
2021
Q4 | $183M | Buy |
|
|||||
|
2021
Q3 | $131M | Buy |
|
|||||
|
2021
Q2 | $334M | Buy |
|
|||||
|
2021
Q1 | $409M | Buy |
|
|||||
|
2020
Q4 | $342M | Buy |
|
|||||
|
2020
Q3 | $291M | Buy |
|
|||||
|
2020
Q2 | $222M | Buy |
|
|||||
|
2020
Q1 | $175M | Buy |
|
|||||
|
2019
Q4 | $44.8M | Buy |
|